A Dallas jury has awarded $73.4 million in the first trial to go against Boston Scientific Corp. over one of its pelvic mesh devices.
Jurors in the 95th Judicial District Court in Dallas County found that the Obtryx transvaginal sling was defectively designed and that Boston Scientific failed to warn doctors about those defects.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
